4001百老汇

Be the most trusted biotech company

2024-06-12

Henlius Shines at 2024 BIO International Convention, Showcasing Its Innovative Strength and Global Achievements
2024-06-07

Henlius Expands Collaboration with Sermonix for Lasofoxifene in All of Asia
2024-06-06

Henlius Trastuzumab Begins its Journey to Saudi Arabia
2024-06-04

Latest Results of Serplulimab Released at 2024 ASCO
2024-05-27

Henlius Rituximab Receives Marketing Approval in Peru
2024-05-24

European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
2024-05-22

The Supplemental Applications of HANDAYUAN(adalimumab injection) for the New Indications Approved by the NMPA
2024-05-21

Henlius to Release Latest Clinical Data of HLX22 at 2024 ESMO GI
2024-05-16

Henlius to Showcase at BIO 2024